Peptide Systems
Private Company
Total funding raised: $1.8M
Overview
Peptide Systems is a long-established, private supplier of research-grade peptides and small molecules, serving the preclinical and basic research markets. Its core value proposition is guaranteed purity and precision, validated by independent, ISO-certified lab certifications for all its products. The company operates a B2B services model, generating revenue by supplying essential tools to academic, pharmaceutical, and biotech researchers. While not a therapeutic developer itself, it supports drug discovery pipelines by providing critical starting materials and enabling early-stage research.
Technology Platform
Integrated quality assurance and supply chain system for peptide/small molecule synthesis, with third-party ISO-certified laboratory validation for all products.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Highly competitive and fragmented, ranging from global giants like Thermo Fisher and Merck KGaA to specialized peptide manufacturers like Bachem and numerous small-scale suppliers. Differentiation is primarily based on price, purity, catalog breadth, and speed, with Peptide Systems competing on certified quality.